EIF4A1
Basic information
Region (hg38): 17:7572824-7579006
Previous symbols: [ "EIF4A" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EIF4A1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 8 | |||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 8 | 1 | 1 |
Variants in EIF4A1
This is a list of pathogenic ClinVar variants found in the EIF4A1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-7572853-C-G | not specified | Uncertain significance (Jun 17, 2024) | ||
17-7572861-C-T | not specified | Uncertain significance (Aug 12, 2022) | ||
17-7574271-A-G | not specified | Uncertain significance (Jan 04, 2024) | ||
17-7574290-G-T | not specified | Uncertain significance (Oct 06, 2024) | ||
17-7575180-G-A | Benign (Dec 17, 2021) | |||
17-7575197-A-G | not specified | Uncertain significance (Nov 14, 2024) | ||
17-7575226-G-A | not specified | Uncertain significance (Dec 14, 2023) | ||
17-7577458-C-T | not specified | Uncertain significance (Feb 26, 2024) | ||
17-7577561-A-G | See cases | Uncertain significance (Oct 10, 2018) | ||
17-7577851-C-T | Autism spectrum disorder | Uncertain significance (Aug 16, 2021) | ||
17-7578345-C-T | not specified | Likely benign (Jul 14, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
EIF4A1 | protein_coding | protein_coding | ENST00000293831 | 11 | 6300 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000134 | 117562 | 0 | 1 | 117563 | 0.00000425 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.93 | 74 | 248 | 0.298 | 0.0000141 | 2679 |
Missense in Polyphen | 12 | 88.757 | 0.1352 | 1076 | ||
Synonymous | -4.09 | 138 | 88.9 | 1.55 | 0.00000504 | 775 |
Loss of Function | 4.67 | 0 | 25.4 | 0.00 | 0.00000156 | 254 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000927 | 0.00000927 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: ATP-dependent RNA helicase which is a subunit of the eIF4F complex involved in cap recognition and is required for mRNA binding to ribosome. In the current model of translation initiation, eIF4A unwinds RNA secondary structures in the 5'-UTR of mRNAs which is necessary to allow efficient binding of the small ribosomal subunit, and subsequent scanning for the initiator codon. {ECO:0000269|PubMed:19153607, ECO:0000269|PubMed:19204291}.;
- Pathway
- RNA transport - Homo sapiens (human);Translation Factors;Interferon type I signaling pathways;mtor signaling pathway;regulation of eif-4e and p70s6 kinase;skeletal muscle hypertrophy is regulated via akt-mtor pathway;internal ribosome entry pathway;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Cytokine Signaling in Immune system;Eukaryotic Translation Initiation;Translation;Metabolism of proteins;Metabolism of RNA;Immune System;insulin Mam;eukaryotic protein translation;Ribosomal scanning and start codon recognition;L13a-mediated translational silencing of Ceruloplasmin expression;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Deadenylation of mRNA;Deadenylation-dependent mRNA decay;mTOR signaling pathway;Validated targets of C-MYC transcriptional activation;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Interferon Signaling;insulin
(Consensus)
Recessive Scores
- pRec
- 0.426
Intolerance Scores
- loftool
- 0.321
- rvis_EVS
- -0.36
- rvis_percentile_EVS
- 28.63
Haploinsufficiency Scores
- pHI
- 0.994
- hipred
- Y
- hipred_score
- 0.831
- ghis
- 0.654
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.992
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Low | Medium |
Primary Immunodeficiency | Medium | Low | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Eif4a1
- Phenotype
Zebrafish Information Network
- Gene name
- eif4a1a
- Affected structure
- trunk
- Phenotype tag
- abnormal
- Phenotype quality
- necrotic
Gene ontology
- Biological process
- translational initiation;viral process
- Cellular component
- nucleus;cytoplasm;cytosol;membrane;eukaryotic translation initiation factor 4F complex;extracellular exosome
- Molecular function
- RNA cap binding;RNA binding;double-stranded RNA binding;mRNA binding;translation initiation factor activity;ATP-dependent RNA helicase activity;helicase activity;protein binding;ATP binding;translation factor activity, RNA binding